Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02907489
Other study ID # CEBD-CU-2016-09-194
Secondary ID
Status Completed
Phase Phase 1
First received
Last updated
Start date October 2016
Est. completion date July 2018

Study information

Verified date September 2019
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the use of triple antibiotic paste as intracanal medication with an anti-inflammatory drug, compared to a calcium hydroxide will reduce postoperative pain and intracanal bacteria or not in patients with asymptomatic necrotic teeth.


Description:

This trial is aiming to answer a clinical question whether in patients with asymptomatic necrotic teeth, the use of triple antibiotic paste as intracanal medication with an anti-inflammatory drug, compared to a calcium hydroxide, reduce postoperative pain and intracanal bacteria or not? trial design will be Randomized, controlled, double blinded, unicenter, parallel, two-arm, superiority trial with 1:1 allocation ratio.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date July 2018
Est. primary completion date April 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

1. Subject's age between 18-50 years.

2. Both male and female subjects.

3. Medically free and healthy subjects.

4. Mandibular and maxillary single rooted teeth.

5. Asymptomatic non vital teeth.

Exclusion Criteria:

1. Teeth with acute dentoalveolar abscess.

2. Subjects having more than one tooth that require root canal treatment.

3. Subjects that have taken analgesic, anti-inflammatory or antibiotic drugs during the 10 days prior to the start of treatment.

4. Pregnant females.

5. Subjects with systemic diseases who have endocrine diseases, Infectious diseases or Psychological disturbance.

6. Teeth with periodontal disease or pulp calcification.

7. Subjects taking chronic pain medications.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
triple antibiotic paste with an anti-inflammatory drug
Mixture of ciprofloxacin, metronidazole and minocycline.and diclofenac potassium 50 mg (Catafast)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary Post Operative Pain Visual Analogue Scale (VAS) of post operative pain (The VAS consisted of a 100 mm horizontal ruler without numbers except a "0" at its first part and a "10" in the last part. With "0" indicating the best outcome while "10" the worst outcome. The subjects were asked to mark the point that was equivalent to their pain intensity. The pain levels were classified as no pain [0], mild pain [1-3], moderate pain [4-7] or severe pain [8-10] ) after 24, 48, and 72 hour from the end of the first visit.
Secondary Intracanal Bacterial Count Colony forming units per milliliter of blood agar medium before root canal preparation (S1), after root canal preparation (S2) and after intracanal medication application for 72 hours (S3) before and after mechanical preparation (at day 0) and after 72 hour from placement of the intracanal medication.